Charles S Berenson1, Ragina L Kruzel, Ellana Eberhardt, Sanjay Sethi. 1. Infectious Disease and Pulmonary Medicine Divisions, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine.
Abstract
BACKGROUND: Alveolar macrophages in chronic obstructive pulmonary disease (COPD) have fundamental impairment of phagocytosis for nontypeable Haemophilus influenzae (NTHI). However, relative selectivity of dysfunctional phagocytosis among diverse respiratory pathogens: NTHI, Moraxella catarrhalis (MC), Streptococcus pneumoniae (SP), and nonbacterial particles, as well as the contribution of impaired phagocytosis to severity of COPD, has not been explored. METHODS: Alveolar macrophages, obtained from nonsmokers (n = 20), COPD ex-smokers (n = 32), and COPD active smokers (n = 64), were incubated with labeled NTHI, MC, SP, and fluorescent microspheres. Phagocytosis was measured as intracellular percentages of each. RESULTS: Alveolar macrophages of COPD ex-smokers and active smokers had impaired complement-independent phagocytosis of NTHI (P = .003) and MC (P = .0007) but not SP or microspheres. Nonetheless, complement-mediated phagocytosis was enhanced within each group only for SP. Defective phagocytosis was significantly greater for NTHI than for MC among COPD active smokers (P < .0001) and ex-smokers (P = .028). Moreover, severity of COPD (FEV1%predicted) correlated with impaired AM phagocytosis for NTHI (P = .0016) and MC (P = .01). CONCLUSIONS: These studies delineate pathogen- and host-specific differences in defective alveolar macrophages phagocytosis of respiratory bacteria in COPD, further elucidating the immunologic basis for bacterial persistence in COPD and provide the first demonstration of association of impaired phagocytosis to severity of disease.
BACKGROUND: Alveolar macrophages in chronic obstructive pulmonary disease (COPD) have fundamental impairment of phagocytosis for nontypeable Haemophilus influenzae (NTHI). However, relative selectivity of dysfunctional phagocytosis among diverse respiratory pathogens: NTHI, Moraxella catarrhalis (MC), Streptococcus pneumoniae (SP), and nonbacterial particles, as well as the contribution of impaired phagocytosis to severity of COPD, has not been explored. METHODS: Alveolar macrophages, obtained from nonsmokers (n = 20), COPD ex-smokers (n = 32), and COPD active smokers (n = 64), were incubated with labeled NTHI, MC, SP, and fluorescent microspheres. Phagocytosis was measured as intracellular percentages of each. RESULTS: Alveolar macrophages of COPD ex-smokers and active smokers had impaired complement-independent phagocytosis of NTHI (P = .003) and MC (P = .0007) but not SP or microspheres. Nonetheless, complement-mediated phagocytosis was enhanced within each group only for SP. Defective phagocytosis was significantly greater for NTHI than for MC among COPD active smokers (P < .0001) and ex-smokers (P = .028). Moreover, severity of COPD (FEV1%predicted) correlated with impaired AM phagocytosis for NTHI (P = .0016) and MC (P = .01). CONCLUSIONS: These studies delineate pathogen- and host-specific differences in defective alveolar macrophages phagocytosis of respiratory bacteria in COPD, further elucidating the immunologic basis for bacterial persistence in COPD and provide the first demonstration of association of impaired phagocytosis to severity of disease.
Authors: Christopher J Harvey; Rajesh K Thimmulappa; Sanjay Sethi; Xiaoni Kong; Lonny Yarmus; Robert H Brown; David Feller-Kopman; Robert Wise; Shyam Biswal Journal: Sci Transl Med Date: 2011-04-13 Impact factor: 17.956
Authors: Jie Li; Jennifer P Wang; Ionita Ghiran; Anna Cerny; Alexander J Szalai; David E Briles; Robert W Finberg Journal: Infect Immun Date: 2010-05-03 Impact factor: 3.441
Authors: John C Phipps; David M Aronoff; Jeffrey L Curtis; Deepti Goel; Edmund O'Brien; Peter Mancuso Journal: Infect Immun Date: 2009-12-14 Impact factor: 3.441
Authors: Jana P Lovell; Christa S Zerbe; Kenneth N Olivier; Reginald J Claypool; Cathleen Frein; Victoria L Anderson; Alexandra F Freeman; Steven M Holland Journal: Ann Am Thorac Soc Date: 2016-12
Authors: Lucia E Rosas; Ola A Elgamal; Xiaokui Mo; Mitch A Phelps; Thomas D Schmittgen; Tracey L Papenfuss Journal: J Immunotoxicol Date: 2016-04-14 Impact factor: 3.000
Authors: Martin A Bewley; Richard C Budd; Eilise Ryan; Joby Cole; Paul Collini; Jennifer Marshall; Umme Kolsum; Gussie Beech; Richard D Emes; Irina Tcherniaeva; Guy A M Berbers; Sarah R Walmsley; Gavin Donaldson; Jadwiga A Wedzicha; Iain Kilty; William Rumsey; Yolanda Sanchez; Christopher E Brightling; Louise E Donnelly; Peter J Barnes; Dave Singh; Moira K B Whyte; David H Dockrell Journal: Am J Respir Crit Care Med Date: 2018-09-15 Impact factor: 21.405
Authors: Stephen B Gordon; Nigel G Bruce; Jonathan Grigg; Patricia L Hibberd; Om P Kurmi; Kin-bong Hubert Lam; Kevin Mortimer; Kwaku Poku Asante; Kalpana Balakrishnan; John Balmes; Naor Bar-Zeev; Michael N Bates; Patrick N Breysse; Sonia Buist; Zhengming Chen; Deborah Havens; Darby Jack; Surinder Jindal; Haidong Kan; Sumi Mehta; Peter Moschovis; Luke Naeher; Archana Patel; Rogelio Perez-Padilla; Daniel Pope; Jamie Rylance; Sean Semple; William J Martin Journal: Lancet Respir Med Date: 2014-09-02 Impact factor: 30.700